As shown in the KEGG and GO enrichment analysis (Figure 5 and Figure 6), there was a significant enrichment of genes related to redox processes in esophageal cancer cells after CAP treatment, as well as enrichment of apoptosis-related signaling pathways such as p53 and oncogenes K-Ras. The gene discussed is TP53; the disease is esophageal cancer.